[{"Assets_0_FY_USD":639254000.0,"CommonStockSharesOutstanding_0_FY_shares":52833000.0,"NetIncomeLoss_1_FY_USD":-67332000.0,"NetIncomeLoss_4_FY_USD":-190669000.0,"StockholdersEquity_0_FY_USD":350231000.0,"Ticker":"TBPH","CIK":"1583107","name":"THERAVANCE BIOPHARMA, INC.","OfficialName":"Theravance Biopharma Inc. Ordinary Shares","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688048421.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170301"}]